Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PROBHE: Prehabilitation with Botulinum Toxin A in Complex Hernia
2025-522451-25-00Phase 2Authorised
- Sponsor
- ASST Ovest Milano
- Start
- Nov 2025
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of botulinum toxin type A in abdominal hernia and incisional hernia, sponsored by ASST Ovest Milano. Primary endpoints: Rectus-to-defect ratio (RDR), Computed tomography-based Component Separation Index (CSI) and 1 more. Planned start Nov 2025; status: authorised.
02
Drugs
botulinum toxin type A
03
Conditions
abdominal herniaincisional hernia
Beyond the preview
Go deeper on 2025-522451-25-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2025-522451-25-00.